Skip to main content
    T

    Translational Development Acquisition Corp. Ordinary Shares (TDAC)

    Official site

    FINANCIAL SERVICES • SHELL COMPANIES • NASDAQ

    $10.85
    -0.01 (-0.09%)

    Market Cap: $209.69M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Translational Development Acquisition Corp. Ordinary Shares (TDAC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a market cap of $209.69M and an enterprise value of $211.76M. Its share count is down 11.86% from a year earlier.

    Total Valuation

    Enterprise value is 0.98% above the market cap, as debt exceeds cash.

    Market Cap$209.69M
    Enterprise Value$211.76M
    Latest price (Nov 17, 2026)$10.85

    Key Dates

    Last Earnings DateAug 14, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 10.22% in the quarter ended Sep 30, 2026 and grew 118.35% a year over 2 years.

    Shares Outstanding19.31M
    Shares Change (YoY)-11.86%
    Shares Change (QoQ)-10.22%
    Share Count Growth (2Y CAGR)+118.35%

    Price Statistics

    The stock is up 4.03% over 52 weeks and trades at its 50-day average.

    Beta (1Y)0.04
    52-Week Change+4.03%
    1-Month Change+0.37%
    3-Month Change+0.05%
    6-Month Change+1.97%
    Total Return (1Y)+4.03%
    Return vs SPY (1Y)-7.53%
    Max Drawdown (1Y)-0.92%
    Sharpe Ratio (1Y)1.54
    Correlation with SPY (1Y)0.21
    50-Day Average$10.85
    200-Day Average$10.72
    52-Week Range$10.41 to $10.95
    RSI (14 Days)49.0
    Average Volume (20 Days)18.33K

    Financial Position

    Current assets cover 0.03x current liabilities.

    Current Ratio0.03x
    Quick Ratio0.03x

    Returns and Efficiency

    Return on invested capital is 55.63% over the last 12 months.

    Return on Assets (ROA)-3.40%
    Return on Invested Capital (ROIC)55.63%

    Scores

    TDAC has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was -$553.29K over the last 12 months.

    Revenue-$553.29K
    Gross Profit-$23.22K
    Operating Income-$1.65M
    Pretax Income-$5.42M
    Net Income-$5.42M
    Reported EPS (TTM)$0.26

    Trailing 12 months through Sep 30, 2026.

    Balance Sheet

    Cash and Equivalents$85.85K
    Total Debt$2.15M
    Net Debt$2.06M
    Net Debt Per Share$0.11
    Working Capital-$2.80M
    Shareholder Equity-$19.03M
    Total Assets$159.41M
    Total Liabilities$19.12M

    Balance sheet as of Sep 30, 2026.

    Cash Flow

    Operating Cash Flow-$1.14M
    FCF Per Share-$0.06

    Trailing 12 months through Sep 30, 2026.

    Dividends and Yields

    TDAC does not pay a dividend.

    Earnings Yield2.38%
    Buyback Yield0.04%
    Shareholder Yield0.04%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TDAC

    What is TDAC's market cap?

    Translational Development Acquisition Corp. Ordinary Shares has a market cap of $209.69M. Its enterprise value, which adds debt and subtracts cash, is $211.76M.

    What is TDAC's P/E ratio?

    Translational Development Acquisition Corp. Ordinary Shares has a trailing P/E ratio of 42.1x.

    How many shares of TDAC are outstanding?

    Translational Development Acquisition Corp. Ordinary Shares has 19.31M shares outstanding. The count is down 11.86% from a year earlier.

    Does TDAC pay a dividend?

    No. Translational Development Acquisition Corp. Ordinary Shares does not pay a dividend.

    How much debt does TDAC have?

    Translational Development Acquisition Corp. Ordinary Shares has $2.15M of total debt and $85.85K of cash and equivalents, a net debt position of $2.06M.